Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: Results from a randomized, double-blind, placebo-controlled study of etanercept

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 1, 2013, Pages 125-128

  Tyring, S ^a   Bagel, J ^b   Lynde, C ^c   Klekotka, P ^d   Thompson, E H Z ^d   Gandra, S R ^d   Shi, Y ^d   Kricorian, G ^d  

^a UNIVERSITY OF TEXAS   (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT;

CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EMOTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; PLAQUE FORMING CELL; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; REFERENCE VALUES; SCALP DERMATOSES; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84872853072     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04394.x     Document Type: Letter

References (7)

1. Gowda S, Goldblum OM, McCall WV, Feldman SR,. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 2010; 63: 114-123.
2. Krueger G, Koo J, Lebwohl M, Menter A, Stern R, Rolstad T,. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-284.
3. Tyring S, Gordon KB, Poulin Y, et al. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis. Arch Dermatol 2007; 143: 719-726.
4. Chan CS, Van Voorhees AS, Lebwohl MG, et al. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2009; 60: 962-971.
5. Papp K, Berth-Jones J, Kragballe K, Wozel G, de la Brassinne M,. Scalp psoriasis: a review of current topical treatment options. J Eur Acad Dermatol Venereol 2007; 21: 1151-1160.
6. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T,. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139.
7. Bagel J, Lynde C, Tyring S, Kricorian G, Shi Y, Klekotka P,. Moderate to severe plaque psoriasis with scalp involvement: a randomized, double-blind, placebo-controlled study of etanercept. J Am Acad Dermatol 2011; Oct 19. [Epub ahead of Print]. PMID:22014541.